Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Cited by (1,000)

Items 101–200 of 1,000

1. Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
   Nicholas Funderburg, Ying Jiang, Sara M. Debanne, Danielle E. Labbato, Steven M. Juchnowski, Brian Ferrari, Brian M. Clagett, Janet Robinson, Michael M. Lederman, Grace A. McComsey · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
2. No Association of Abacavir Use With Myocardial Infarction
   Xiao Xia Ding, Eugenio Andraca‐Carrera, Charles K. Cooper, Peter Miele, Cynthia J. Kornegay, Mat Soukup, Kendall A. Marcus · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
3. Ritonavir-boosted protease inhibitors in HIV therapy
   Mark Hull, Julio S. G. Montaner · 2011 · Annals of Medicine
4. Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection
   Jason V. Baker, Jacqueline Neuhaus, Daniel A. Duprez, Lewis H. Kuller, Russell P. Tracy, Waldo Horacio Belloso, Stéphane De Wit, Fraser Drummond, Henry Clifford Lane, Bruno Ledergerber et al. · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
5. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial
   Alexandra Calmy, Angèle Gayet‐Ageron, Fabrizio Montecucco, Alain Nguyen, François Mach, Fabienne Burger, Sasiwimol Ubolyam, Andrew D Carr, Kiat Ruxungtham, Bernard J. Hirschel et al. · 2009 · AIDS
6. HIV Replication and Immune Status Are Independent Predictors of the Risk of Myocardial Infarction in HIV-Infected Individuals
   Sylvie Lang, Murielle Mary‐Krause, Anne Simon, Marialuisa Partisani, Jacques Gilquin, Laurent Cotte, Franck Boccara, Dominique G. Costagliola · 2012 · Clinical Infectious Diseases
7. HIV infection in the elderly
   Mark Holodniy, Nancy Nguyen · 2008 · Clinical Interventions in Aging
8. Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
   Andy I. Choi, Eric Vittinghoff, Steven G. Deeks, Cristin C. Weekley, Yongmei Li, Michael G. Shlipak · 2011 · AIDS
9. High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
   Anuradha Ganesan, Nancy F. Crum‐Cianflone, Jeanette M. Higgins, Jing Qin, Catherine A. Rehm, Julia A. Metcalf, Carolyn Brandt, Jean Vita, Catherine F. Decker, Peter A. Sklar et al. · 2011 · The Journal of Infectious Diseases
10. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population
    Daniel R. Drozd, Mari M. Kitahata, Keri N. Althoff, Jinbing Zhang, Stephen J. Gange, Sonia Napravnik, Greer Burkholder, William C. Mathews, Michael Jonah Silverberg, Timothy R. Sterling et al. · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
11. Abacavir use and cardiovascular disease events
    Mario Cruciani, Veronica Zanichelli, Giovanni Serpelloni, Oliviero Bosco, Marina Malena, Romualdo Mazzi, Carlo Mengoli, Saverio Giuseppe Parisi, Graeme J Moyle · 2011 · AIDS
12. HIV infection and high density lipoprotein metabolism
    Honor May Rose, Jennifer Hoy, Ian John Woolley, Urbain Tchoua, Michael Bukrinsky, Anthony Michael Dart, Dmitri Sviridov · 2007 · Atherosclerosis
13. Cigarette Smoking in the HIV-Infected Population
    Shiva Rahmanian, Mary Ellen Wewers, Susan L. Koletar, Nancy Reynolds, Amy K. Ferketich, P. Diaz · 2011 · Proceedings of the American Thoracic Society
14. Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors
    Benoît Chauvin, Sylvain Drouot, Aurélie Barrail‐Tran, Anne‐Marie Taburet · 2013 · Clinical Pharmacokinetics
15. Risk of cerebrovascular events in persons with and without HIV
    Line Dahlerup Rasmussen, Frederik Neess Engsig, Hanne Christensen, Jan Gerstoft, Gitte Kronborg, Court Pedersen, Niels Obel · 2011 · AIDS
16. Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era
    Enrico Cerrato, Fabrizio D’Ascenzo, Giuseppe Biondi‐Zoccai, Andrea Calcagno, Simone Frea, Walter Grosso Marra, Davide Castagno, Pier Luigi Omedè, Giorgio Quadri, Filippo Sciuto et al. · 2013 · European Heart Journal
17. No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT
    Heather Jane Ribaudo, Constance Ann Benson, Yu Zheng, Susan L. Koletar, Ann C. Collier, Judith J. Lok, Marlene Smurzynski, Ronald J. Bosch, B. Bastow, Jeffrey T. Schouten et al. · 2011 · Clinical Infectious Diseases
18. The macrophage: the intersection between HIV infection and atherosclerosis
    Suzanne M. Crowe, Clare L V Westhorpe, Nigora Mukhamedova, Anthony Jaworowski, Dmitri Sviridov, Michael Bukrinsky · 2009 · Journal of Leukocyte Biology
19. Abacavir Use and Risk of Acute Myocardial Infarction and Cerebrovascular Events in the Highly Active Antiretroviral Therapy Era
    Roger Bedimo, Andrew O. Westfall, Henning Drechsler, Gabriela Vidiella, Pablo Tebas · 2011 · Clinical Infectious Diseases
20. HIV Infection and Coronary Heart Disease: An Intersection of Epidemics
    Virginia A. Triant · 2012 · The Journal of Infectious Diseases
21. Outcomes After Acute Myocardial Infarction in HIV-Infected Patients
    Luc Lorgis, Jonathan Cottenet, G. Molins, Éric Benzenine, Marianne Zeller, Hervé Aube, Claude Touzery, Joëlle Hamblin, Aurélie Gudjoncik, Yves Cottin et al. · 2013 · Circulation
22. Abacavir and risk of myocardial infarction in HIV‐infected patients on highly active antiretroviral therapy: a population‐based nationwide cohort study
    Niels Obel, Dóra Körmendiné Farkas, Gitte Kronborg, Carsten Schade Larsen, Gitte Pedersen, Anders Hammerich Riis, Claus Duedal Pedersen, Jan Gerstoft, Henrik Toft Sørensen · 2009 · HIV Medicine
23. Lipid Abnormalities and Inflammation in HIV Inflection
    Nicholas Funderburg, Nehal N. Mehta · 2016 · Current HIV/AIDS Reports
24. HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease
    Appakkudal R. Anand, Gladys Rachel, Durgadevi Parthasarathy · 2018 · Frontiers in Cardiovascular Medicine
25. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium
    Bastian Neesgaard, Lauren Greenberg, José María Miró, Katharina Grabmeier‐Pfistershammer, Gilles Wandeler, Colette J Smith, Stéphane De Wit, Ferdinand W.N.M. Wit, Annegret Pelchen–Matthews, Cristina Mussini et al. · 2022 · The Lancet HIV
26. Myocardial Infarction Among Danish HIV-Infected Individuals: Population-Attributable Fractions Associated With Smoking
    Line Dahlerup Rasmussen, Marie Helleberg, Margaret May, Shoaib Afzal, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Jan Gerstoft, Børge Grønne Nordestgaard, Niels Obel · 2015 · Clinical Infectious Diseases
27. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs
    Joel da Cunha · 2015 · World Journal of Virology
28. HIV-associated dyslipidaemia: pathogenesis and treatment
    Jisun Oh, Robert Alexander Hegele · 2007 · The Lancet Infectious Diseases
29. HIV and the heart: the impact of antiretroviral therapy: a global perspective
    Friedrich Thienemann, Karen S Sliwa, Jürgen Kurt Rockstroh · 2013 · European Heart Journal
30. Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western Kenya
    Gerald S. Bloomfield, Joseph W. Hogan, Alfred Keter, Edwin Sang, E. Jane Carter, Eric J. Velazquez, Sylvester N. Kimaiyo · 2011 · PLoS ONE
31. Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature
    Michael P. Dubé, Steven E. Lipshultz, Carl J. Fichtenbaum, Richard Neil Greenberg, Alison D. Schecter, Stacy D. Fisher, for Working Group 3 · 2008 · Circulation
32. HIV and Ischemic Heart Disease
    Ahmed Vachiat, Keir R.G. McCutcheon, Nqoba Tsabedze, Don Zachariah, Pravin Manga · 2017 · Journal of the American College of Cardiology
33. British HIV Association guidelines for the treatment of HIV ‐1‐positive adults with antiretroviral therapy 2015
    Duncan R. Churchill, Laura Jane Waters, Nadia Ahmed, Brian Angus, Marta Boffito, Mark Bower, David T. Dunn, Simon Edwards, Carol Emerson, Sarah J. Fidler et al. · 2016 · HIV Medicine
34. HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected Patients
    Donald P. Kotler · 2008 · JAIDS Journal of Acquired Immune Deficiency Syndromes
35. Efavirenz: a decade of clinical experience in the treatment of HIV
    Franco Maggiolo · 2009 · Journal of Antimicrobial Chemotherapy
36. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
    Estebán Martínez, Polyana Monteiro d’Albuquerque, Josep Maria Llibre, Félix Gutiérrez, Daniel Podzamczer, Antonio Antela, Juan Berenguer, Peré Domingo, X. Cases Moreno, Ignacio Pérez et al. · 2012 · AIDS
37. HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis
    David B. Hanna, Wendy S. Post, Jennifer A. Deal, Howard Neil Hodis, Lisa P. Jacobson, Wendy Jean Mack, Kathryn Anastos, Stephen J. Gange, ALAN L. LANDAY, Jason Lazar et al. · 2015 · Clinical Infectious Diseases
38. High Prevalence of Peripheral Arterial Disease in HIV-Infected Persons
    Daniel Périard, Matthias L. Cavassini, Patrick Taffé, M. Chevalley, Laurence Senn, Caroline Chapuis‐Taillard, Serge De Vallière, Daniel Hayoz, PHILIP E. TARR, for the Swiss HIV Cohort Study · 2008 · Clinical Infectious Diseases
39. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study
    Lawrence Kingsley, Juliana Cuervo-Rojas, Álvaro Muñoz, Frank Joseph Palella, Wendy S. Post, Mallory D. Witt, Matthew Jay Budoff, Lewis H. Kuller · 2008 · AIDS
40. Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us
    Kate A. Buchacz, Rose K. Baker, Frank Joseph Palella, Lauren Shaw, Pragna Patel, Kenneth A. Lichtenstein, Joan Sander Chmiel, Claudia J. Vellozzi, R. Debes, Keith Henry et al. · 2012 · Antiviral Therapy
41. HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies
    Edward A Hulten, Joshua D. Mitchell, J Scally, B Gibbs, Todd C. Villines · 2009 · Heart
42. Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection
    Saurabh Mehandru, Brigitta A. Vcelar, Terri Wrin, Gabriela M. Stiegler, Béda Joos, Hiroshi Mohri, Daniel Boden, Justin Galovich, Klara Tenner‐Racz, Paul Rácz et al. · 2007 · Journal of Virology
43. Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
    for the D:A:D Study Group, Caroline Anne Sabin, Peter Reiss, Lene Ryom, Andrew N. Phillips, Rainer K. Weber, Matthew G. Law, Éric Fontas, Amanda Mocroft, Stéphane De Wit et al. · 2016 · BMC Medicine
44. Cardiovascular disease in patients with hemophilia
    Attie Tuinenburg, Eveline P. Mauser‐Bunschoten, Marianne Christina Verhaar, Douwe Hedde Biesma, Roger E. G. Schutgens · 2009 · Journal of Thrombosis and Haemostasis
45. Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus
    Paul Edward Sax, Jürgen Kurt Rockstroh, Anne F. Luetkemeyer, Yazdan Yazdanpanah, Douglas J. Ward, Benoît Trottier, Armin Rieger, Hui Liu, Rima K Acosta, Sean E Collins et al. · 2020 · Clinical Infectious Diseases
46. Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial
    José Ramón Arribas, Gilles Pialoux, Joseph Gathe, Giovanni Di Perri, Jacques Reynes, Pablo Tebas, Thai Nguyen, Ramin Ebrahimi, Kirsten White, David M. Piontkowsky · 2014 · The Lancet Infectious Diseases
47. Review: The Need for Smoking Cessation Among HIV-Positive Smokers
    Shadi Nahvi, Nina A. Cooperman · 2009 · AIDS Education and Prevention
48. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis
    Franck Boccara, Murielle Mary‐Krause, Emmanuel Teíger, Sylvie Lang, Pascal Lim, Karim Wahbi, Farzin Beygui, Olivier Milleron, Philippe Gabríel Steg, Christian Funck‐Brentano et al. · 2010 · European Heart Journal
49. Long-Term Survival and Serious Cardiovascular Events in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy
    Samuel A. Bozzette, Christopher F. Ake, Henry K. Tam, Alba E. Phippard, David Cohen, Daniel O. Scharfstein, Thomas A. Louis · 2008 · JAIDS Journal of Acquired Immune Deficiency Syndromes
50. Cardiovascular disease in HIV infection
    Frank Joseph Palella, John Phair · 2011 · Current Opinion in HIV and AIDS
51. HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era
    Gerald S. Bloomfield, Prateeti Khazanie, Alison M. Morris, Cristina Rabadan‐Diehl, Laura A. Benjamin, David Murdoch, Virginia S. Radcliff, Eric J. Velazquez, Charles B. Hicks · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
52. Association of Age and Comorbidity with Physical Function in HIV-Infected and Uninfected Patients: Results from the Veterans Aging Cohort Study
    Krisann K. Oursler, Joseph Lucien Goulet, Stephen Crystal, Amy C. Justice, Kristina A. Crothers, Adeel Ajwad Butt, Maria C. Rodriguez‐Barradas, Knachelle Favors, David A. Leaf, Leslie Ira Katzel et al. · 2011 · AIDS Patient Care and STDs
53. Cardiac manifestations of HIV infection: an African perspective
    Mpiko Ntsekhe, Bongani M. Mayosi · 2008 · Nature Clinical Practice Cardiovascular Medicine
54. The aging of the HIV epidemic
    Kavita Bhavan, Vinay N. Kampalath, Edgar Turner Overton · 2008 · Current HIV/AIDS Reports
55. Mechanism for Effective Lymphoid Cell and Tissue Loading Following Oral Administration of Nucleotide Prodrug GS-7340
    Darius M. Babusis, Truc K. Phan, William A. Lee, William J. Watkins, Adrian S. Ray · 2012 · Molecular Pharmaceutics
56. Comorbidities and depression in older adults with HIV
    Richard J. Havlik, Mark Brennan‐Ing, Stephen E. Karpiak · 2011 · Sexual Health
57. Cystatin C, Albuminuria, and 5-Year All-Cause Mortality in HIV-Infected Persons
    Andy I. Choi, Rebecca Scherzer, Peter Bacchetti, Phyllis C. Tien, Michael S. Saag, Cynthia L. Gibert, Lynda Anne M. Szczech, Carl Grünfeld, Michael G. Shlipak · 2010 · American Journal of Kidney Diseases
58. Review: Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era
    Nancy F. Crum‐Cianflone, Jhamillia Weekes, Mary F. Bavaro · 2008 · AIDS Patient Care and STDs
59. Physical activity correlates in people living with HIV/AIDS: a systematic review of 45 studies
    Davy Vancampfort, James Mugisha, Justin A. Richards, Marc D. Binder, Michel Probst, Brendon Stubbs · 2017 · Disability and Rehabilitation
60. Nevirapine versus Atazanavir/Ritonavir, Each Combined with Tenofovir Disoproxil Fumarate/Emtricitabine, in Antiretroviral-Naive HIV-1 Patients: The Arten Trial
    ARTEN investigators, Vincent Soriano, Keikawus Arastéh, Horacio Migrone, Thomas Lutz, Milos Opravil, Jaime Federico Andrade-Villanueva, Francisco Antunes, Giovanni Di Perri, Daniel Podzamczer et al. · 2010 · Antiviral Therapy
61. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder
    Pasquale Mansueto, Aurelio Seidita, Giustina Vitale, Sebastiano Gangemi, Chiara Iaria, Antonio Cascio · 2015 · BioMed Research International
62. Nonclassical Biological Activities of Quinolone Derivatives
    Mohsen Daneshtalab, Abeer A Ahmed · 2011 · Journal of Pharmacy & Pharmaceutical Sciences
63. Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
    Antonella d’Arminio Monforte, Peter Reiss, Lene Ryom, Wafaa M. El-Sadr, François Dabis, Stéphane De Wit, Signe Westring Worm, Matthew G. Law, Rainer K. Weber, Ole Kirk et al. · 2013 · AIDS
64. Risk of coronary heart disease in patients with HIV infection
    Markella V. Zanni, J. Schouten, Steven Kyle Grinspoon, Peter Reiss · 2014 · Nature Reviews Cardiology
65. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients
    Nicholas Funderburg · 2013 · Current Opinion in HIV and AIDS
66. Co‐morbidity in the ageing haemophilia patient: the down side of increased life expectancy
    Eveline P. Mauser‐Bunschoten, Dietje E. Fransen van de Putte, Roger E. G. Schutgens · 2009 · Haemophilia
67. Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients
    Julian Alexander Luetkens, Jonas Doerner, Carolynne Schwarze‐Zander, Jan‐Christian Wasmuth, Christoph Boesecke, Alois Martin Sprinkart, Frederic Carsten Schmeel, Rami Homsi, Juergen Gieseke, Hans Heinz Schild et al. · 2016 · Circulation Cardiovascular Imaging
68. Common adverse effects of antiretroviral therapy for HIV disease.
    Carin Reust · 2011 · PubMed
69. Cardiovascular manifestations of HIV infection
    Jennifer E. Ho, Priscilla Y. Hsue · 2009 · Heart
70. Cardiovascular Complications in HIV Management: Past, Present, and Future
    Judith A. Aberg · 2008 · JAIDS Journal of Acquired Immune Deficiency Syndromes
71. A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science
    Allison R. Webel, Julie K. Schexnayder, Patricia A. Cioe, Julie Ann Zuniga · 2021 · Journal of the Association of Nurses in AIDS Care
72. The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications
    Oliver P. Flint, Mustafa A. Noor, Paul W. Hruz, Phillip B. Hylemon, Kevin E. Yarasheski, Donald P. Kotler, Rex A. Parker, Aouatef Bellamine · 2009 · Toxicologic Pathology
73. Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy
    Marit G. A. van Vonderen, Yvo Michiel Smulders, Coen D.A. Stehouwer, Sven A. Danner, Chad M. Gundy, Frieda Vos, Peter Reiss, Michiel A. van Agtmael · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
74. Clinical use of CCR5 inhibitors in HIV and beyond
    Bruce L. Gilliam, David James Riedel, Robert Redfield · 2011 · Journal of Translational Medicine
75. Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure
    Raza M. Alvi, Anne M. Neilan, Noor Tariq, Magid Awadalla, Maryam Afshar, Dahlia Banerji, Adam Rokicki, Connor P. Mulligan, Virginia A. Triant, Markella V. Zanni et al. · 2018 · Journal of the American College of Cardiology
76. Hospitalization for Pneumonia among Individuals With and Without HIV Infection, 1995–2007: A Danish Population‐Based, Nationwide Cohort Study
    Ole Schmeltz Søgaard, Nicolai Lohse, Jan Gerstoft, Gitte Kronborg, Lars Jørgen Østergaard, Court Pedersen, Gitte Pedersen, Henrik Toft Sørensen, Niels Obel · 2008 · Clinical Infectious Diseases
77. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV‐infected patients: relationships with serum markers of oxidation and inflammation
    Sandra Parra, Blai Coll, Gerard Aragonès, Judit Marsillach, Raúl Beltrán‐Debón, Anna Rull, Jorge Joven, Carlos Alonso‐Villaverde, Jordi Camps · 2009 · HIV Medicine
78. Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus
    Signe Westring Worm, Stéphane De Wit, Rainer K. Weber, Caroline Anne Sabin, Peter Reiss, Wafaa El‐Sadr, Antonella d’Arminio Monforte, Ole Kirk, Éric Fontas, François Dabis et al. · 2009 · Circulation
79. Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals
    Julia L. Marcus, Romain S. Neugebauer, Wendy A. Leyden, Chun Chao, Lanfang Xu, Charles P. Quesenberry, Daniel Benjamin Klein, William James Towner, Michael Alan Horberg, Michael Jonah Silverberg · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
80. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy
    F. D’Ascenzo, Enrico Cerrato, Giuseppe Biondi‐Zoccai, Claudio Moretti, Pier Luigi Omedè, Filippo Sciuto, Mario Bollati, Maria Grazia Modena, Fiorenzo Gaïta, Imad Sheiban · 2011 · European Heart Journal
81. High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern Uganda
    Daniel M. Muyanja, Conrad K. Muzoora, Anthony Muyingo, Winnie R. Muyindike, Mark Jacob Siedner · 2015 · AIDS Patient Care and STDs
82. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors
    Franck Boccara · 2008 · AIDS
83. Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review
    Suelen Jorge Souza, Liânia Alves Luzia, Sigrid de Sousa dos Santos, Patrícia Helen de Carvalho Rondó · 2013 · Revista da Associação Médica Brasileira
84. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort
    Jason V. Baker, Katherine Huppler Hullsiek, Amrit Singh, Eleanor M. P. Wilson, Keith Henry, Ken Lichtenstein, Nur F. Önen, Erna M. Kojic, Pragna Patel, John T. Brooks et al. · 2013 · AIDS
85. The Roles of HIV-1 Proteins and Antiretroviral Drug Therapy in HIV-1-Associated Endothelial Dysfunction
    Erik R. Kline, Roy L. Sutliff · 2008 · Journal of Investigative Medicine
86. Metabolic Effects of Darunavir/Ritonavir Versus Atazanavir/Ritonavir in Treatment-Naive, HIV Type 1-Infected Subjects over 48 Weeks
    Judith A. Aberg, Pablo Tebas, Edgar Turner Overton, Samir Kumar Gupta, Paul Edward Sax, ALAN L. LANDAY, Ron Falcon, Robert J. Ryan, Guy De La Rosa · 2012 · AIDS Research and Human Retroviruses
87. Vascular endothelial dysfunction in the wake of HIV and ART
    Clara Marincowitz, Amanda Genis, Nandu Goswami, Patrick De Boever, Tim S. Nawrot, Hans Strijdom · 2018 · FEBS Journal
88. Increased Platelet Reactivity in HIV-1–Infected Patients Receiving Abacavir-Containing Antiretroviral Therapy
    Claudette S. Satchell, Jane A. O’Halloran, Aoife G. Cotter, Aaron J. Peace, Eileen O’Connor, Anthony F. Tedesco, Eoin R. Feeney, John Shearer Lambert, Gerard J. Sheehan, Dermot J. Kenny et al. · 2011 · The Journal of Infectious Diseases
89. Pathophysiology and management of cardiovascular disease in patients with HIV
    Eric Nou, Janet Lo, Colleen M. Hadigan, Steven Kyle Grinspoon · 2016 · The Lancet Diabetes & Endocrinology
90. Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates
    Ivona Pandrea, Elaine S. Cornell, Cara C. Wilson, Ruy Miguel Ribeiro, Dongzhu Ma, Jan Kristoff, Cuiling Xu, George Sebastian Haret-Richter, Anita M. Trichel, Cristian Apetrei et al. · 2012 · Blood
91. HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms
    Hong C. Lai, Richard D. Moore, David D. Celentano, Gary Gerstenblith, Glenn J. Treisman, Jeanne C. Keruly, Thomas S. Kickler, Ji Li, Shaoguang Chen, Shenghan Lai et al. · 2016 · Journal of the American Heart Association
92. Quinolone 3-Carboxylic Acid Pharmacophore: Design of Second Generation HIV-1 Integrase Inhibitors
    Raveendra Dayam, Laith Q. Al‐Mawsawi, Zahrah Zawahir, Myriam Witvrouw, Zeger Debyser, Nouri Neamati · 2008 · Journal of Medicinal Chemistry
93. Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks
    Romina Quercia, JEREMY N. ROBERTS, Louise Martin-Carpenter, Carlos Zala · 2015 · Clinical Drug Investigation
94. The Burden of Diabetes and Hyperlipidemia in Treated HIV Infection and Approaches for Cardiometabolic Care
    Katherine Samaras · 2012 · Current HIV/AIDS Reports
95. A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results
    Michael J. Kozal, Sergio Lupo, Edwin DeJesus, Jean‐Michel Molina, Cheryl McDonald, François Raffi, Jorge A. Benetucci, Marco Mancini, Rong Yang, Victoria Wirtz et al. · 2012 · HIV Clinical Trials
96. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease
    Jennifer E. Ho, Rebecca Scherzer, Frederick M. Hecht, Kristinalisa Maka, Van N. Selby, Jeffrey N. Martin, Peter Ganz, Steven G. Deeks, Priscilla Y. Hsue · 2012 · AIDS
97. Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study
    Nico Reinsch, Kathrin Neuhaus, Stefan Eßer, Anja Verena Potthoff, Martin Hower, Sarah Mostardt, Anja Neumann, Norbert Hermann Brockmeyer, Götz Gelbrich, Raimund Erbel et al. · 2011 · European Journal of Preventive Cardiology
98. Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients
    Chotikorn Khunnawat, Siddharth Mukerji, Daniel H. Havlichek, Rabih N. Touma, George S. Abela · 2008 · The American Journal of Cardiology
99. Microbial Translocation in HIV Infection Is Associated With Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction
    Karin Kaereby Pedersen, Maria Pedersen, Marius Trøseid, Julie Christine Gaardbo, Tamara T. Lund, Carsten Thomsen, Jan Gerstoft, Dag Kvale, Susanne Dam Nielsen · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
100. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals
     Jennifer E. Ho, Steven G. Deeks, Frederick M. Hecht, Yu Xie, Amanda Schnell, Jeffrey N. Martin, Peter Ganz, Priscilla Y. Hsue · 2010 · AIDS